ESC 365 - SGLT2 inhibitors in HFmrEF and HFpEF: fulfilling an unmet need?

HFA Premium Access

SGLT2 inhibitors in HFmrEF and HFpEF: fulfilling an unmet need?

Session: SGLT2 inhibitors across the spectrum of heart failure

Topic: Chronic Heart Failure

Speaker: Professor M. Petrie (Glasgow, GB)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Mark Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

47 presentations

8 followers

4 more presentations in this session

Decoding cardio-protection with SGLT2 inhibitors: new insights into cardio-renal mechanisms.

Speaker: Professor P. Seferovic (Belgrade, RS)

SGLT2 inhibitors: major cardiovascular outcomes in ambulatory patients with HFrEF.

Speaker: Professor G. Rosano (London, GB)

SGLT2 inhibitors in worsening and decompensated heart failure: a promising perspective.

Speaker: Professor P. Ponikowski (Wroclaw, PL)

SGLT2 inhibitors across the spectrum of heart failure - discussion.

Access the full session

SGLT2 inhibitors across the spectrum of heart failure

Speakers: Professor M. Petrie, Professor P. Seferovic, Professor G. Rosano, Professor P. Ponikowski

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources